Exact Mass: 843.322

Exact Mass Matches: 843.322

Found 16 metabolites which its exact mass value is equals to given mass value 843.322, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(6S)-6-amino-N-[1-[3-[[4-[(2S)-2-amino-2-[4-[2-[[3-[1-[[(6S)-6-amino-3-oxoheptanoyl]amino]cyclopropyl]-3-oxopropanoyl]amino]acetyl]-1,3-thiazol-2-yl]acetyl]-1,3-thiazol-2-yl]methylamino]-3-oxopropanoyl]cyclopropyl]-3-oxoheptanamide

(6S)-6-amino-N-[1-[3-[[4-[(2S)-2-amino-2-[4-[2-[[3-[1-[[(6S)-6-amino-3-oxoheptanoyl]amino]cyclopropyl]-3-oxopropanoyl]amino]acetyl]-1,3-thiazol-2-yl]acetyl]-1,3-thiazol-2-yl]methylamino]-3-oxopropanoyl]cyclopropyl]-3-oxoheptanamide

C37H49N9O10S2 (843.3044)

methyl 8-{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl]oxy}nonanoate

C35H59N2O21- (843.361)

methyl 8-{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl]oxy}nonanoate

C35H59N2O21- (843.361)

DDHepalpha1-6DDHepalpha1-2DDHepalpha1-2DDHepalphaO[CH2]3NH2

C31H57NO25 (843.322)

FC131 (TFA)

C38H48F3N11O8 (843.3639)

FC131 TFA is a CXCR4 antagonist, inhibits [125I]-SDF-1 binding to CXCR4, with an IC50 of 4.5 nM. Anti-HIV activity[1].

2-{15-[9-(3-bromo-4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl}ethanimidic acid

2-{15-[9-(3-bromo-4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl}ethanimidic acid

C38H50BrN7O10 (843.2802)

methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2r,3s,6s)-3-hydroxy-6-methyl-5-oxooxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2r,3s,6s)-3-hydroxy-6-methyl-5-oxooxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H53NO17 (843.3313)

(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid

(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid

C38H50BrN7O10 (843.2802)

2-{15-[9-(3-bromo-4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl}ethanimidic acid

2-{15-[9-(3-bromo-4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl}ethanimidic acid

C38H50BrN7O10 (843.2802)

(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid

(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid

C38H50BrN7O10 (843.2802)

(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-3-[(2r)-butan-2-yl]-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid

(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-3-[(2r)-butan-2-yl]-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid

C38H50BrN7O10 (843.2802)

2-[(2-{[2-({2-[(4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene)amino]-1,3-dihydroxypropylidene}amino)-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene)amino]-5-(n-hydroxyformamido)pentanoic acid

2-[(2-{[2-({2-[(4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene)amino]-1,3-dihydroxypropylidene}amino)-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene)amino]-5-(n-hydroxyformamido)pentanoic acid

C34H53N9O16 (843.361)

(2s)-2-{[(2r)-2-{[(2s)-2-{[(2r)-2-{[(3s,4s)-4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene]amino}-1,3-dihydroxypropylidene]amino}-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-5-(n-hydroxyformamido)pentanoic acid

(2s)-2-{[(2r)-2-{[(2s)-2-{[(2r)-2-{[(3s,4s)-4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene]amino}-1,3-dihydroxypropylidene]amino}-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-5-(n-hydroxyformamido)pentanoic acid

C34H53N9O16 (843.361)